Argument & Sources

Should states launch clinical trials for repurposed drugs that may help treat cancers?

Public funding for trials on off-patent drugs unprofitable for pharma.

15 votes|10 arguments|0 source

73%11

2/5 Arguments

Repurposed drugs are cheap and have known safety profiles. Even modest efficacy gains would deliver huge population health value. @@yes_2

Comparative overview of how surrogacy is regulated across 46 European jurisdictions, from outright bans to fully commercial frameworks.